Natalizumab Treatment of Progressive Multiple Sclerosis

Conditions

• Primary Progressive Multiple Sclerosis
• Secondary Progressive Multiple Sclerosis

Interventions

• DRUG: Natalizumab

Sponsor

Rigshospitalet, Denmark

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]